Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,266

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,852

Class I recallsReasonable probability of serious health consequences

24,397

Class II recallsTemporary or medically reversible health consequences

2,897

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,085 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/pan-pepin-inc-emite-alerta-por-alergenos-en-el-producto-parabien-al-grano-debido-la-presencia-dePublished October 13, 2026

Most affected stateHawaii 200 recalls mention this state

State: GU ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 14, 2026 ET

Summary (Year to date)

1,739 recalls have been announced year to date.
Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (300).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,397
Class I	9,852
Class III	2,897
Not Yet Classified	2

FDA Recall Ongoing2026 recordClass II

Zicam, Cold Remedy, Medicated Nasal Swabs, With Cooling Menthol & Eucalyptus, 20 Single-Use Swabs per carton, Zinc-Free Homeopathic, Distributed by Church & Dwight Co. Inc., Ewing, NJ 08628, UPC 732216301205.

by Church & Dwight Co., Inc.

Reason: CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Pithampur (MP) 454 775, INDIA, NDC 68180-956-04.

by Lupin Pharmaceuticals Inc.

Reason: Failed content uniformity specifications.
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-count bottles (NDC 16729-456-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-455-17.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), packaged in a) 90-count bottles (NDC 16729-454-15) b) 1000-count bottles (NDC 16729-454-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-453-17.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-452-17.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451-15) and b) 1000-count bottles, (NDC 16729-451-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-17.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-449-17.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-448-17.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-447-17.

by ACCORD HEALTHCARE, INC.

Reason: Subpotent Drug
Published: September 2, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDC 72572-470-01) and b) 10x10 mL Single Dose Vials (NDC 72572-470-10), Rx Only, Mfd for: Civica, Inc., Lehi, UT, Mfd by: American Regent, Inc., New Albany, OH 43054.

by American Regent, Inc.

Reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published: August 26, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Tralement (trace elements injection 4*, USP), packaged in a) 1mL Single Dose vials (NDC 0517-9305-01) and b) 5x1mL Single Dose vials (NDC 0517-9305-25), Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published: August 26, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass I

Papaverine HCl Injection, USP, 60 mg/2 mL (30 mg/mL), packaged in a) 2mL Single-Dose Vial (NDC 0517-4002-01), and b) 25x2mL Single-Dose Vials (NDC 0517-4002-25), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde
Published: August 26, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Multrys (Trace Elements Injection 4, USP), For intravenous infusion, packaged in a) 1 mL Single-Dose Vial (NDC 0517-9302-01), and b) 25x1 mL Single-Dose Vials (NDC 0517-9302-25) Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published: August 26, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

Selenious Acid Injection, USP 12 mcg/2 mL (6 mcg/2mL), For intravenous use, packaged in a) 2mL Single-Dose Vial (NDC 0517-6502-01), and b)10x2mL Single-Dose Vial (NDC 0517-6502-10), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published: August 26, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

ACETYLCYSTEINE SOLUTION, USP, 20% (200 mg/mL), packaged in a) 4 mL Vial NOT FOR INJECTION (NDC 0517-7604-01), and b) 25x4 mL Vials NOT FOR INJECTION (NDC 0517-7604-25), Rx only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

by American Regent, Inc.

Reason: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
Published: August 26, 2026
Distribution: Nationwide

View recall →

Data last updated: October 14, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.